Correction: A Conformation-Sensitive Monoclonal Antibody against the A2 Domain of von Willebrand Factor Reduces Its Proteolysis by ADAMTS13

Correction: A Conformation-Sensitive Monoclonal Antibody against the A2 Domain of von Willebrand Factor Reduces Its Proteolysis by ADAMTS13

Show other versions (1)

Bibliographic Details
Main Authors:	Jingyu Zhang, Zhenni Ma, Ningzheng Dong, Fang Liu, Jian Su, Yiming Zhao, Fei Shen, Anyou Wang, Changgeng Ruan
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2011-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3182151/?tool=EBI

Similar Items

A conformation-sensitive monoclonal antibody against the A2 domain of von Willebrand factor reduces its proteolysis by ADAMTS13.
by: Jingyu Zhang, et al.
Published: (2011-01-01)

Correction: A Conformation-Sensitive Monoclonal Antibody against the A2 Domain of von Willebrand Factor Reduces Its Proteolysis by ADAMTS13.
by: Jingyu Zhang, et al.
Published: (2011-01-01)

A novel monoclonal antibody against the von Willebrand Factor A2 domain reduces its cleavage by ADAMTS13
by: Lulu Zhang, et al.
Published: (2017-02-01)

Characterization of conformation-sensitive antibodies to ADAMTS13, the von Willebrand cleavage protease.
by: Zuben E Sauna, et al.
Published: (2009-08-01)

ADAMTS13 : molecular recognition of Von Willebrand factor
by: Zanardelli, Sara
Published: (2006)

Identification and functional analysis of a novel von Willebrand factor mutation in a family with type 2A von Willebrand disease.
by: Jing Dong, et al.
Published: (2012-01-01)

Imbalance of von Willebrand factor and ADAMTS13 in hemodialysis patients.
by: Wei-Ting Liao, et al.
Published: (2017)

Von Willebrand factor, ADAMTS13 and mortality in dialysis patients
by: Gurbey Ocak, et al.
Published: (2021-06-01)

A common mechanism by which type 2A von Willebrand disease mutations enhance ADAMTS13 proteolysis revealed with a von Willebrand factor A2 domain FRET construct.
by: Christopher J Lynch, et al.
Published: (2017-01-01)

PROTEOLYTIC PROCESSING OF VON WILLEBRAND FACTOR BY ADAMTS13 AND LEUKOCYTE PROTEASES
by: Stefano Lancellotti, et al.
Published: (2013-09-01)

Increased Von Willebrand factor, decreased ADAMTS13 and thrombocytopenia in melioidosis.
by: Emma Birnie, et al.
Published: (2017-03-01)

The Intriguing Relationships of von Willebrand Factor, ADAMTS13 and Cardiac Disease
by: Benjamin Reardon, et al.
Published: (2021-09-01)

Púrpura trombocitopênica trombótica: o papel do fator von Willebrand e da ADAMTS13 Thrombotic thrombocytopenic purpura: the role of von Willebrand factor and ADAMTS13
by: Leandro C. Tonaco, et al.
Published: (2010-01-01)

Correction: Increased Von Willebrand factor, decreased ADAMTS13 and thrombocytopenia in melioidosis.
by: Emma Birnie, et al.
Published: (2020-09-01)

Von Willebrand Factor and ADAMTS13 in COVID-19 and Beyond: A Question of Balance
by: Emmanuel J Favaloro, et al.
Published: (2021-07-01)

Quantification of von Willebrand factor and ADAMTS-13 after traumatic injury: a pilot study
by: Taleen A MacArthur, et al.
Published: (2021-08-01)

The chimeric monoclonal antibody MHCSZ-123 against human von Willebrand factor A3 domain inhibits high-shear arterial thrombosis in a Rhesus monkey model
by: Shundong Ji, et al.
Published: (2017-05-01)

Von Willebrand factor glycans : modifiers of function & proteolysis
by: McKinnon, Thomas Antony Jude
Published: (2007)

Characterization of ADAMTS13 and von Willebrand factor levels in septic and non-septic ICU patients.
by: Kanwal Singh, et al.
Published: (2021-01-01)

Secretion of von Willebrand Factor and Suppression of ADAMTS-13 Activity by Markedly High Concentration of Ferritin
by: Dalia A. Bashir MD, et al.
Published: (2021-02-01)

Insights Into Immunothrombosis: The Interplay Among Neutrophil Extracellular Trap, von Willebrand Factor, and ADAMTS13
by: Junxian Yang, et al.
Published: (2020-12-01)

Comparison of levels of von Willebrand factor and ADAMTS13 in Patients of Myocardial Infarction and Healthy Controls
by: Shamila Tahir, et al.
Published: (2019-05-01)

Plasmatic ADAMTS-13 metalloprotease and von Willebrand factor in children with cyanotic congenital heart disease
by: R.P.S. Soares, et al.
Published: (2013-04-01)

Severe dengue is associated with consumption of von Willebrand factor and its cleaving enzyme ADAMTS-13.
by: Kis Djamiatun, et al.
Published: (2012-01-01)

Plasmatic ADAMTS-13 metalloprotease and von Willebrand factor in children with cyanotic congenital heart disease
by: R.P.S. Soares, et al.
Published: (2013-05-01)

Plasma ADAMTS13 and von Willebrand factor in diagnosis and prediction of prognosis in pulmonary arterial hypertension
by: Abdulla Ahmed, et al.
Published: (2021-09-01)

Von Willebrand Factor and ADAMTS13 as Predictors of Adverse Outcomes in Patients With Nonvalvular Atrial Fibrillation
by: Waldemar E. Wysokinski, MD, PhD, et al.
Published: (2021-03-01)

Studies on monoclonal antibodies to Von Willebrand factor and coagulation factor VIII
by: Hornsey, Valerie Scott
Published: (1988)

Clinical significance of measuring ADAMTS-13, its inhibitor and von Willebrand factor in obstetric and gynecological practice
by: K. N. Grigoreva, et al.
Published: (2021-03-01)

PROTEOLYTIC PROCESSING OF VON WILLEBRAND FACTOR BY ADAMTS13 AND LEUKOCYTE PROTEASES-rev1-MJHID-2013
by: Raimondo De Cristofaro
Published: (2014-08-01)

Multiple functions of the von Willebrand Factor A domain in matrilins: secretion, assembly, and proteolysis
by: Kanbe Katsuaki, et al.
Published: (2008-06-01)

Severe Plasmodium falciparum malaria is associated with circulating ultra-large von Willebrand multimers and ADAMTS13 inhibition.
by: Deirdre Larkin, et al.
Published: (2009-03-01)

The role of ADAMTS‐13 and von Willebrand factor in cancer patients: Results from the Vienna Cancer and Thrombosis Study
by: Hanna L. Obermeier, et al.
Published: (2019-07-01)

The Prognostic Value of ADAMTS-13 and von Willebrand Factor in COVID-19 Patients: Prospective Evaluation by Care Setting
by: Giovanni Tiscia, et al.
Published: (2021-09-01)

The role of von Willebrand factor and its cleaving protease, ADAMTS13, in young patients with HIV-related stroke.
by: Allie, Sameera
Published: (2014)

ADAMTS13 and von Willebrand factor assessment in steady state and acute vaso‐occlusive crisis of sickle cell disease
by: Julien Demagny, et al.
Published: (2021-01-01)

Prospective Evaluation of the Pre-, Intra-, and Postoperative Kinetics of ADAMTS-13, von Willebrand Factor, and Interleukin-6 in Vascular Surgery
by: Katja Susanne Häußler MD, et al.
Published: (2020-10-01)

Von Willebrand Factor, ADAMTS13 and D-Dimer Are Correlated with Different Levels of Nephropathy in Type 1 Diabetes Mellitus.
by: Caroline Pereira Domingueti, et al.
Published: (2015-01-01)

Increased von Willebrand Factor to ADAMTS13 Ratio as a Predictor of Thrombotic Complications Following a Major Hepatectomy
by: 小林, 真一郎, et al.
Published: (2014)

Pré-eclâmpsia: avaliação de fator VIII, fator de Von Willebrand e Adamts-13 e do grupo sanguíneo ABO
by: Patricia Nessralla Alpoim
Published: (2010)

Cannot write session to /tmp/vufind_sessions/sess_n67r2gsrd6rsei3443bfgiu7t6